Platelet count in heart failure patients undergoing left ventricular assist device

Area of Science:

• Cardiology
• Biomedical Engineering
• Hematology

Background:

• Left ventricular assist device (LVAD) implantation is a critical therapy for end-stage heart failure.
• LVAD use is known to be associated with platelet (PLT) activation and potential complications.

Purpose of the Study:

• To investigate the prognostic significance of pre- and post-implantation platelet counts in patients receiving continuous-flow LVADs.
• To evaluate the dynamic changes in platelet counts following LVAD implantation and their association with long-term survival.

Main Methods:

• Analysis of data from 19,517 patients who received their first continuous-flow LVAD, sourced from the INTERMACS registry.
• Patients were stratified into tertiles based on pre- and post-implant platelet counts.
• Statistical analysis was performed to assess the association between platelet counts and long-term mortality, including a U-shaped curve analysis.

Main Results:

• Platelet counts demonstrated a trend toward normalization after LVAD implantation.
• Both high and low pre-implant platelet counts were associated with an increased risk of 2-year mortality compared to intermediate counts.
• Elevated post-implant platelet counts correlated with a higher risk of 4-year mortality, indicating a U-shaped association between platelet levels and mortality.

Conclusions:

• LVAD implantation can contribute to normalizing platelet counts in heart failure patients.
• Deviations from normal platelet counts, both before and after LVAD implantation, are independent predictors of increased long-term mortality risk.